These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33289601)

  • 21. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
    Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
    Liu Z; Wang N; Wang F; Zhang S; Ding J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA FAM83H-AS1 promotes oesophageal squamous cell carcinoma progression via miR-10a-5p/Girdin axis.
    Feng B; Wang G; Liang X; Wu Z; Wang X; Dong Z; Guo Y; Shen S; Liang J; Guo W
    J Cell Mol Med; 2020 Aug; 24(16):8962-8976. PubMed ID: 32583631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.
    Liu N; Zhang C; Zhang L
    Mol Biotechnol; 2024 Aug; 66(8):1883-1893. PubMed ID: 37477820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
    Chen Q; Fu L
    PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A.
    Hu CC; Liang YW; Hu JL; Liu LF; Liang JW; Wang R
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6602-6611. PubMed ID: 31378902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1.
    Luo XJ; Lu YX; Wang Y; Huang R; Liu J; Jin Y; Liu ZK; Liu ZX; Huang QT; Pu HY; Zeng ZL; Xu R; Zhao Q; Wu QN
    Cancer Lett; 2024 Aug; 598():217085. PubMed ID: 38964733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
    Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
    J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
    Liu CN; Zhang HY; Liu CL; Wang CC
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21).
    Bi YY; Shen G; Quan Y; Jiang W; Xu F
    J Cell Physiol; 2018 Nov; 233(11):8896-8907. PubMed ID: 29870057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of the long non-coding RNA FAM83H-AS1 in gastric cancer and its clinical significance.
    Da J; Liu P; Wang R; Bu L
    Pathol Res Pract; 2019 Oct; 215(10):152616. PubMed ID: 31493939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing UNC5B antisense lncRNA 1 represses growth and metastasis of human Colon cancer cells via raising miR-622.
    Zhang Y; Li Z; Lan Z
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):60-67. PubMed ID: 31852293
    [No Abstract]   [Full Text] [Related]  

  • 34. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.
    Luo H; Yang L; Liu C; Wang X; Dong Q; Liu L; Wei Q
    Int J Biochem Cell Biol; 2020 May; 122():105702. PubMed ID: 32087328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.
    Chen Z; Chen X; Xie R; Huang M; Dong W; Han J; Zhang J; Zhou Q; Li H; Huang J; Lin T
    Mol Ther; 2019 Feb; 27(2):326-341. PubMed ID: 30660488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA OIP5-AS1 exhibits oncogenic activity in bladder cancer through miR-217 and MTDH.
    Zhang SF; Pang S; Wang FP; Li XY; Zou Q
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3211-3220. PubMed ID: 33928606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer.
    Yuan X; Huang Y; Guo M; Hu X; Li P
    J Ovarian Res; 2021 Jan; 14(1):6. PubMed ID: 33413565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.